InspireMD Statistics

Total Valuation

InspireMD has a market cap or net worth of $70.15 million. The enterprise value is $46.39 million.

Market Cap	70.15M
Enterprise Value	46.39M

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025, before market open.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

InspireMD has 30.64 million shares outstanding. The number of shares has increased by 48.89% in one year.

Current Share Class	30.64M
Shares Outstanding	30.64M
Shares Change (YoY)	+48.89%
Shares Change (QoQ)	+2.26%
Owned by Insiders (%)	23.76%
Owned by Institutions (%)	22.66%
Float	16.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.80
Forward PS	8.28
PB Ratio	2.54
P/TBV Ratio	2.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.60
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.36, with a Debt / Equity ratio of 0.08.

Current Ratio	4.36
Quick Ratio	3.86
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -113.95% and return on invested capital (ROIC) is -69.83%.

Return on Equity (ROE)	-113.95%
Return on Assets (ROA)	-58.16%
Return on Invested Capital (ROIC)	-69.83%
Return on Capital Employed (ROCE)	-119.95%
Revenue Per Employee	$81,709
Profits Per Employee	-$420,221
Employee Count	86
Asset Turnover	0.17
Inventory Turnover	2.13

Taxes

In the past 12 months, InspireMD has paid $59,000 in taxes.

Income Tax	59,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.11% in the last 52 weeks. The beta is 0.61, so InspireMD's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	-8.11%
50-Day Moving Average	2.47
200-Day Moving Average	2.67
Relative Strength Index (RSI)	41.96
Average Volume (20 Days)	356,915

Short Selling Information

The latest short interest is 195,681, so 0.64% of the outstanding shares have been sold short.

Short Interest	195,681
Short Previous Month	204,654
Short % of Shares Out	0.64%
Short % of Float	1.16%
Short Ratio (days to cover)	4.08

Income Statement

In the last 12 months, InspireMD had revenue of $7.03 million and -$36.14 million in losses. Loss per share was -$0.79.

Revenue	7.03M
Gross Profit	1.51M
Operating Income	-37.55M
Pretax Income	-25.46M
Net Income	-36.14M
EBITDA	-37.24M
EBIT	-37.55M
Loss Per Share	-$0.79

Full Income Statement

Balance Sheet

The company has $26.09 million in cash and $2.32 million in debt, giving a net cash position of $23.76 million or $0.78 per share.

Cash & Cash Equivalents	26.09M
Total Debt	2.32M
Net Cash	23.76M
Net Cash Per Share	$0.78
Equity (Book Value)	28.35M
Book Value Per Share	0.95
Working Capital	24.78M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$25.60 million and capital expenditures -$1.57 million, giving a free cash flow of -$27.16 million.

Operating Cash Flow	-25.60M
Capital Expenditures	-1.57M
Free Cash Flow	-27.16M
FCF Per Share	-$0.89

Full Cash Flow Statement

Margins

Gross Margin	21.43%
Operating Margin	-534.35%
Pretax Margin	-513.45%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

InspireMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-48.89%
Shareholder Yield	-48.89%
Earnings Yield	-51.51%
FCF Yield	-38.72%

Analyst Forecast

The average price target for InspireMD is $4.50, which is 96.51% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.50
Price Target Difference	96.51%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 27, 2021. It was a reverse split with a ratio of 0.0666666667:1.

Last Split Date	Apr 27, 2021
Split Type	Reverse
Split Ratio	0.0666666667:1

Scores

InspireMD has an Altman Z-Score of -7.89 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.89
Piotroski F-Score	1